MMAP Client Story 5:

I met with a client who reviews her supplemental plan every year with me. She has multiple health conditions and takes a lot of medications. Her current plan will no longer cover her insulin (Lantus Solostar pens) in 2018 and had sent her a letter listing three other lower-cost insulin brands that they will cover. As any insulin-dependent diabetic knows, switching to a different insulin is not that easy. Often times a patient and doctor work for many months to get the right combination of medications to maintain consistent glucose readings. A switch in brands could be detrimental to someone’s health. In comparing plans, we were able to find several other plans that would cover all of her medications and she chose to enroll in a new plan for 2018 at a total annual savings of $15,231. She was relieved that she did not have to try a different insulin.